20-F: Afya Limited Reports Financial Results for Fiscal Year 2024

Afya Limited releases its 20-F filing, highlighting financial performance and key business activities for the year ended December 31, 2024.

Summary

• Afya Limited has released its financial results for the fiscal year 2024.
• The company's functional currency is the Brazilian Real, and financial statements are prepared in accordance with IFRS.
• As of December 31, 2024, Afya had 76,988 enrolled students.
• The company operates in three segments: Undergrad, Continuing Education, and Medical Practice Solutions.
• Revenue for 2024 reached R$3,304.3 million, a 14.9% increase from 2023.
• Net income for 2024 was R$648.9 million, a 60.1% increase from 2023.
• Adjusted EBITDA for 2024 totaled R$1,455.6 million, a 23.0% increase from 2023.
• The company had net cash flows from operating activities of R$1,433 million in 2024.
• The company's operating cash conversion ratio was 102.2% for 2024.
• The company is implementing a tax reform in Brazil, which could lead to material changes in taxation of products and services.
• The company is subject to supervision by MEC and may suffer sanctions as a result of non-compliance with any regulatory requirements.
• The company is subject to anti-corruption, anti-bribery and anti-money laundering laws and regulations.
• The company is subject to environmental laws and regulations, which may become more stringent in the future and increase obligations and capital expenditures with respect to their compliance.
• The company is exposed to occupational health and safety and accident risks.
• The company is exposed to climate change risks that could adversely affect it.
• The company is dependent on the operations of its subsidiaries.
• The company is subject to data privacy regulations.
• The company faces risks relating to its Medical Practice Solutions segment.
• The company may not be able to maintain or renew its existing leases.
• The company is exposed to risks relating to the concentration of ownership and voting power in Bertelsmann, its controlling shareholder.
• The company is exposed to risks relating to the potential sale of Class A common shares.
• The company is exposed to risks relating to the possibility of being a passive foreign investment company (PFIC).
• On March 12, 2025, the board of directors approved the distribution of the first-ever dividends.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and strategic growth initiatives. However, it also acknowledges several risks and challenges, preventing a higher sentiment score.

Positives

• Afya Limited's revenue increased by 14.9% to R$3,304.3 million in 2024.
• Net income rose by 60.1% to R$648.9 million in 2024.
• Adjusted EBITDA increased by 23.0% to R$1,455.6 million in 2024.
• Operating cash conversion ratio was 102.2% in 2024.
• The company had 76,988 enrolled students as of December 31, 2024.
• The company had 3,593 approved medical school seats as of December 31, 2024.
• On March 12, 2025, the board of directors approved the distribution of the first-ever dividends.

Negatives

• The company is implementing a tax reform in Brazil, which could lead to material changes in taxation of products and services.
• The company is subject to supervision by MEC and may suffer sanctions as a result of non-compliance with any regulatory requirements.
• The company is subject to anti-corruption, anti-bribery and anti-money laundering laws and regulations.
• The company is subject to environmental laws and regulations, which may become more stringent in the future and increase obligations and capital expenditures with respect to their compliance.
• The company is exposed to occupational health and safety and accident risks.
• The company is exposed to climate change risks that could adversely affect it.
• The company is dependent on the operations of its subsidiaries.
• The company is subject to data privacy regulations.
• The company faces risks relating to its Medical Practice Solutions segment.
• The company may not be able to maintain or renew its existing leases.
• The company is exposed to risks relating to the concentration of ownership and voting power in Bertelsmann, its controlling shareholder.
• The company is exposed to risks relating to the potential sale of Class A common shares.
• The company is exposed to risks relating to the possibility of being a passive foreign investment company (PFIC).

Risks

• The company is implementing a tax reform in Brazil, which could lead to material changes in taxation of products and services.
• The company is subject to supervision by MEC and may suffer sanctions as a result of non-compliance with any regulatory requirements.
• The company is subject to anti-corruption, anti-bribery and anti-money laundering laws and regulations.
• The company is subject to environmental laws and regulations, which may become more stringent in the future and increase obligations and capital expenditures with respect to their compliance.
• The company is exposed to occupational health and safety and accident risks.
• The company is exposed to climate change risks that could adversely affect it.
• The company is dependent on the operations of its subsidiaries.
• The company is subject to data privacy regulations.
• The company faces risks relating to its Medical Practice Solutions segment.
• The company may not be able to maintain or renew its existing leases.
• The company is exposed to risks relating to the concentration of ownership and voting power in Bertelsmann, its controlling shareholder.
• The company is exposed to risks relating to the potential sale of Class A common shares.
• The company is exposed to risks relating to the possibility of being a passive foreign investment company (PFIC).

Future Outlook

The company expects to continue growing organically and through acquisitions, focusing on medical education and digital health services. They aim to increase student enrollments, expand their B2B capabilities, and develop new products.

Industry Context

Afya operates in the growing Brazilian medical education market, which is driven by factors such as an aging population, increasing demand for healthcare services, and a shortage of medical professionals. The company is the largest medical education group in Brazil based on the number of medical school seats.

Comparison to Industry Standards

• The document does not contain enough information to make a detailed comparison to industry standards.
• A full comparison would require a deeper dive into the financial results of its competitors, such as Yduqs, Ser Educacional, and Kroton, and a comparison of key metrics like revenue growth, profitability, and student enrollment.
• A full comparison would also require a deeper dive into the financial results of its competitors, such as Sanar, MedCof, and Estratgia MED, and a comparison of key metrics like revenue growth, profitability, and student enrollment.
• A full comparison would also require a deeper dive into the financial results of its competitors, such as iClinic, Memed, and Doctoralia, and a comparison of key metrics like revenue growth, profitability, and active users.

Legal Proceedings

• The company and its subsidiaries are subject to a number of judicial and administrative proceedings in the Brazilian court systems, including civil, labor and tax law and social security claims and other proceedings, which we believe are common and incidental to business operations in Brazil, in general.

Related Party Transactions

• The company has entered into lease agreements with RVL Esteves Gesto Imobiliria S.A., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer.
• The company has entered into a lease agreement with UNIVAO Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Ms. Rosngela de Oliveira Tavares Esteves is the chief executive officer.
• The company has entered into a lease agreement with IESVAP Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Tavares Esteves is an executive officer.

Stakeholder Impact

• The company's performance impacts shareholders through stock value and potential dividends.
• Employees are affected by compensation, benefits, and job security.
• Students benefit from the quality of education and career opportunities.
• Customers (patients) benefit from the quality of medical professionals trained by the company.
• Suppliers and creditors are impacted by the company's ability to meet its financial obligations.

Next Steps

• The company plans to continue growing organically and through acquisitions.
• The company plans to continue to selectively pursue M&A opportunities.
• The company plans to continue to develop new products.
• The company plans to continue to expand its distribution network.
• The company plans to continue to leverage infrastructure and extract synergies from acquisitions.
• The company plans to continue to cross-sell across its existing medical student base.
• The company plans to continue to expand its B2B capabilities.
• The company plans to continue to expand its presence and performance in the distance learning business.
• The company plans to continue to open new campuses in connection with the Mais Mdicos II program.
• The company plans to continue to expand its medical residency preparation enrollments base.
• The company plans to continue to expand its graduate programs enrollments base.
• The company plans to continue to enter into new markets.

Key Dates

Keywords

financial results, medical education, Afya Limited, 20-F filing, Brazil, education